| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.3 | 0.006 |